Linaprove 5 mg contains Linagliptin, a DPP-4 inhibitor that enhances insulin secretion in response to meals, thereby lowering blood sugar levels in individuals with type 2 diabetes mellitus. Linagliptin works by blocking the enzyme DPP-4, which in turn increases the levels of incretin hormones such as GLP-1 and GIP. These hormones stimulate insulin release and decrease glucagon secretion, leading to improved blood sugar control. By effectively managing blood glucose levels, Linaprove 5 mg helps reduce the risk of diabetes-related complications and promotes a healthier lifestyle for individuals with type 2 diabetes mellitus.